Price Chart

Profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
URL https://www.merck.com
Investor Relations URL https://www.merck.com/investor-relations
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release Apr. 26, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date Mar. 14, 2024
Last Ex-Dividend Date Dec. 14, 2023

Profile

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
URL https://www.merck.com
Investor Relations URL https://www.merck.com/investor-relations
HQ State/Province New Jersey
Sector Healthcare
Industry Drug Manufacturers - General
Equity Style Large Cap/Value
Next Earnings Release Apr. 26, 2024 (est.)
Last Earnings Release Feb. 01, 2024
Next Ex-Dividend Date Mar. 14, 2024
Last Ex-Dividend Date Dec. 14, 2023